Outcomes in Patients With Immune Checkpoint Inhibitor–Related Myopathy and Prolonged Follow-Up
Yahel Segal(Mayo Clinic), Αναστασία Ζεκερίδου(Mayo Clinic), Ronen Stoff(Mayo Clinic), Georgios Mangioris(Mayo Clinic), Divyanshu Dubey(Mayo Clinic in Arizona), Eoin P. Flanagan(Mayo Clinic in Arizona), Andrew McKeon(Mayo Clinic), Lisa A. Kottschade(Mayo Clinic in Arizona), Elie Naddaf(Mayo Clinic), Sean J. Pittock(Mayo Clinic), Michel Toledano
Cited by 5
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758